Loading clinical trials...
Loading clinical trials...
Phase 1 Dose-Escalation Study of LY2157299 Monotherapy in Patients With Solid Tumors
Conditions
Interventions
LY2157299
Locations
1
Japan
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559 ) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Tokyo, Japan
Start Date
November 1, 2012
Primary Completion Date
June 1, 2014
Completion Date
June 1, 2014
Last Updated
July 1, 2014
NCT07213804
NCT07169851
NCT00026884
NCT07159659
NCT07191730
NCT06662786
Lead Sponsor
Eli Lilly and Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions